Drug Profile
NCX 1000
Alternative Names: NCX-1000; NO-ursodeoxycholic acid; NO-ursodiolLatest Information Update: 15 May 2007
Price :
$50
*
At a glance
- Originator NicOx
- Class Cholic acids; Nitrates
- Mechanism of Action Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Portal hypertension
Most Recent Events
- 15 May 2007 Discontinued - Phase-I for Portal hypertension in USA (PO)
- 15 May 2007 Discontinued - Phase-II for Portal hypertension in Europe (PO)
- 30 Apr 2007 NCX 1000 is still in active development